4893 GI/2017

jftLVªh laö Mhö ,yö&33004@99 REGD. NO. D. L.-33004/99

vlk/kj.k

EXTRAORDINARY

Hkkx II—[k.M 3—mi&[k.M (ii) PART II—Section 3—Sub-section (ii)

izkf/dkj ls izdkf'kr PUBLISHED BY AUTHORITY

la- 2282] ubZ fnYyh] 'kqØokj] vxLr 11] 2017@Jko.k 20] 1939 No. 2282] NEW DELHI, FRIDAY, AUGUST 11, 2017/SRAVANA 20, 1939

jlk;u vkSj moZjd ea=ky;jlk;u vkSj moZjd ea=ky;jlk;u vkSj moZjd ea=ky;jlk;u vkSj moZjd ea=ky;

¼vkS¼vkS¼vkS¼vkS””””k/k foHkkx½k/k foHkkx½k/k foHkkx½k/k foHkkx½

¼jk¼jk¼jk¼jk””””Vªh; vkSVªh; vkSVªh; vkSVªh; vkS””””k/k ewY; fu/kkZj.k izkf/kdj.k½k/k ewY; fu/kkZj.k izkf/kdj.k½k/k ewY; fu/kkZj.k izkf/kdj.k½k/k ewY; fu/kkZj.k izkf/kdj.k½

vkns’kvkns’kvkns’kvkns’k

ubZ fnYyh] 11 vxLr] 2017

dkdkdkdk----vkvkvkvk---- 2601¼v½2601¼v½2601¼v½2601¼v½----& & & & Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 vkSj dk- vk- 701¼v½ rkjh[k 10 ekpZ] 2016 ds lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkns'k] 2013 ds iSjk 4] 5] 6] 10] 11] 14] 15] 16] 17 vkSj 18 }kjk iznRr 'kfDr;ksa dk iz;ksx djrs gq,] jk”Vªh; vkS”k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftls laf{kIr :i ls ,uihih, dgk tkrk gS½ uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ”V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa Øe’k% rRLFkkuh izfof”V;ksa esa fofufnZ”V [kqjkd :i ,oa izcyrk vkSj bdkbZ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof”V esa fofufnZ”V vuqlwfpr fofufeZfr;ksa esa ls izR;sd dh] oLrq ,oa lsok dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds :i esa fu;r djrh gS%

lkj.khlkj.khlkj.khlkj.kh

dz-la- vuqlwfpr fofufeZfr dk uke [kqjkd :i ,oa izcyrk bdkbZ vf/kdre

dher ¼#-½

(1) (2) (3) (4) (5)

1. feMktksye xksyh 7-5 fexzk- 1 xksyh 20.37

2. csatkbZy isulhyhu batsD’ku ds fy, ikmMj 10 yk[k ;wfuV izfr iSd 4.72

3. isjk-,feukslsfyflfyd ,flM xzkuqysl ¼ykbZlsal ds vuqlkj½ 1 xzke 2.58

4. bQksLQkekbZM batsD’ku ds fy, ikmMj 2 xzke izfr iSd 861.83

5. DyksDlkflfyu xksyh 250 fexzk- 1 xksyh 1.57

6. fjQkcqfVu xksyh 150 fexzk- 1 xksyh 33.61

2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]

uksV %uksV %uksV %uksV %

¼d½ ljdkj }kjk bl izdkj fu;r dh xbZ vkSj vf/klwfpr dh xbZ vf/kdre dher ¼/ku oLrq ,oa lsok dj] tks ykxw gksa½ ls vf/kd dher ij vuqlwfpr fofufeZfr;ksa ds czkaMsM ;k tsusfjd ;k nksuksa :ikarjksa dks csp jgs vuqlwfpr fofufeZfr;ksa ds lHkh fofuekZrk] mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ¼/ku oLrq ,oa lsok dj] tks ykxw gksa½ ls vf/kd lHkh ,slh fofufeZr;ksa dh dher dk v/kkseq[kh iqujh{k.k djsaxsA

¼[k½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher oLrq ,oa lsok dj lfgr ls de gS rks] tgka dgh Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 13¼2½ ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA

¼x½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os oLrq ,oa lsok dj dks tksM+ ldrs gSaA

¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr lEcfU/kr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24 ds rgr QkWeZ&V esa vf/klwpuk dh rkjh[k ls vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks ,d ewY; lwph tkjh djsa rFkk mldh dkWih jkT; vkS”kf/k fu;a=dksa vkSj fofuekZrk forjdksa dks tkjh djsaA

¼M+½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjk 24 ¼4½ ds mica/kksa ds vuqlkj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i esa ,sls ifjlj] tgka dkjksckj dks bl izdkj fd;k tk jgk gS fd mlls ijke’kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`’; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf’kZr djsxkA

¼p½ mi;qZDr lkj.kh esa ;Fkk fofufnZ"V [kqnjk ;k izcyrk ;k nksuksa ds lkFk vuqlwfpr fofufeZfr dk dksbZ ekStwnk fofuekZrk vkS”k/k ewY; fu;a=.k vkns’k] 2013 ds iSjk 2¼;w½ ds vuqlkj dksbZ ubZ vkS”kf/k dks ykap djrk gS rks ,sls ekStwnk fofuekZrk dks vkS”k/k ¼ewY; fu;a=.k½ vkns’k 2013 dh vuqlwph&II ds varxZr ;Fkk fofufnZ”V QkeZ&I esa ,uihih, dks ,slh ubZ vkS”kf/k ds ewY; iwoZ vuqeksnu gsrq vkosnu djuk gksxkA

¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds lwph II ds QkWeZ III dks vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lwpuk ,uihih, dks voxr djk;sxkA blds lEcU/k esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA

¼Tk½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n'kkZ;s vf/kdre ewY; vkSj 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA

¼>½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V ,slh fofufeZfr;ksa ds iSdksa dh vf/kdre dher fu;r gksus ds ifj.kkeLo#i] vf/kdre ;k [kqnjk ewY; fu/kkZfjr vkns'k ;fn dksbZ gks] tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh vf/kØe.k gks tk;saxsA

[dka-la-@180@48@2017@,Q@Qk- la- 8¼48½@2017@Mhih@,uihih,&fMoh- II]

cythr flag] ] ] ] lgk;d funs'kd

MINISTRY OF CHEMICALS AND FERTILIZERS

(Department of Pharmaceuticals)

(NATIONAL PHARMACEUTICAL PRICING AUTHORITY)

ORDER

New Delhi, the 11th August, 2017

S.O. 2601(E).—In exercise of the powers conferred by paragraphs 4, 5, 6, 10, 11, 14, 15, 16, 17 and 18 of the

Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 701(E) dated 10th

March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National

Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the prices as specified in column (5) of

the table herein below as ceiling price exclusive of goods and services tax applicable, if any, in respect of the Scheduled

formulations specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and

unit specified respectively in the corresponding entries in columns (3) and (4) thereof:

¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 3

TABLE

Note:

(a) All manufacturers of scheduled formulations, selling the branded or generic or both the versions of scheduled

formulations at a price higher than the ceiling price (plus goods and services tax as applicable) so fixed and notified by

the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in

column (5) in the above table plus goods and services tax as applicable, if any.

(b) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling

price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to

maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.

(c) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the

Government on the ceiling price mentioned in column (5) of the above said table.

(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in

accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11

of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of

Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug

Controller and dealers.

(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price

list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a

manner so as to be easily accessible to any person wishing to consult the same.

(f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the

above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for

prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.

(g) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of

production/import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS.

Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to

the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form-IV of Schedule-

II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.

(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit

the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read

with Essential Commodities Act, 1955.

(i) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this

notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification,

stand(s) superseded.

[PN/180/48/2017/F/F. No. 8(48)/2017/D.P./NPPA-Div.-II]

BALJIT SINGH, Assistant Director

Sl. No. Name of the Scheduled

Formulation

Dosage form & Strength Unit Ceiling Price

(Rs.)

(1) (2) (3) (4) (5)

1. Midazolam Tablet 7.5mg 1 Tablet 20.37

2. Benzyl penicillin Powder for Injection 10 Lac Units Each Pack 4.72

3. Para-aminosalicylic acid Granules (As licensed) 1 Gram 2.58

4. Ifosfamide Powder for Injection 2g Each Pack 861.83

5. Cloxacillin Tablet 250mg 1 Tablet 1.57

6. Rifabutin Tablet 150mg 1 Tablet 33.61

4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]

vkns’kvkns’kvkns’kvkns’k

ubZ fnYyh] 11 vxLr] 2017

dkdkdkdk----vkvkvkvk---- 2602¼v½2602¼v½2602¼v½2602¼v½----&&&&Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 vkSj dk- vk- 701¼v½ rkjh[k 10 ekpZ] 2016 ds lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkns'k] 2013 ds iSjk 4] 6] 10] 11] 14] 16] 17 vkSj 18 }kjk iznRr 'kfDr;ksa dk iz;ksx djrs gq, vkSj Hkkjr ljdkj esa jlk;u ,oa moZjd ea=ky; ¼jk”Vªh; vkS”k/k ewY; fu/kkZj.k izkf/kdj.k½ ds dk- vk- 2060¼v½ fnukad 30 twu] 2017 ¼ dz-la- 10&11½ ds vkns’k ds vf/kdze.k esa tgka rd mldk laca/k uhps dh lkj.kh ds fofufeZfr iSd ls gS] mu ckrksa ds flok; vf/kØkUr djrs gq, ftUgsa ,sls vf/kØe.k ds iwoZ fd;k x;k gS ;k djus dk yksi fd;k x;k gS] jk”Vªh; vkS”k/k ewY; fu/kkZj.k izkf/kdj.k uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ”V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa Øe’k% rRLFkkuh izfof”V;ksa esa fofufnZ”V [kqjkd :i ,oa izcyrk vkSj bdkbZ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof”V esa fofufnZ”V vuqlwfpr fofufeZfr;ksa esa ls izR;sd dh] oLrq ,oa lsok dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds :i esa fu;r djrh gS%

lkj.khlkj.khlkj.khlkj.kh

uksV % uksV % uksV % uksV %

¼d½ ljdkj }kjk bl izdkj fu;r dh xbZ vkSj vf/klwfpr dh xbZ vf/kdre dher ¼/ku oLrq ,oa lsok dj] tks ykxw gksa½ ls vf/kd dher ij vuqlwfpr fofufeZfr;ksa ds czkaMsM ;k tsusfjd ;k nksuksa :ikarjksa dks csp jgs vuqlwfpr fofufeZfr;ksa ds lHkh fofuekZrk] mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ¼/ku oLrq ,oa lsok dj] tks ykxw gksa½ ls vf/kd lHkh ,slh fofufeZr;ksa dh dher dk v/kkseq[kh iqujh{k.k djsaxsA

¼[k½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher oLrq ,oa lsok dj lfgr ls de gS rks] tgka dgh Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 13¼2½ ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA

¼x½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os oLrq ,oa lsok dj dks tksM+ ldrs gSaA

¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr lEcfU/kr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24 ds rgr QkWeZ&V esa vf/klwpuk dh rkjh[k ls vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks ,d ewY; lwph tkjh djsa rFkk mldh dkWih jkT; vkS”kf/k fu;a=dksa vkSj fofuekZrk forjdksa dks tkjh djsaA

¼M+½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjk 24 ¼4½ ds mica/kksa ds vuqlkj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i esa ,sls ifjlj] tgka dkjksckj dks bl izdkj fd;k tk jgk gS fd mlls ijke’kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`’; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf’kZr djsxkA

¼p½ mi;qZDr lkj.kh esa ;Fkk fofufnZ"V [kqnjk ;k izcyrk ;k nksuksa ds lkFk vuqlwfpr fofufeZfr dk dksbZ ekStwnk fofuekZrk vkS”k/k ewY; fu;a=.k vkns’k] 2013 ds iSjk 2¼;w½ ds vuqlkj dksbZ ubZ vkS”kf/k dks ykap djrk gS rks ,sls ekStwnk fofuekZrk dks vkS”k/k ¼ewY; fu;a=.k½ vkns’k 2013 dh vuqlwph&II ds varxZr ;Fkk fofufnZ”V QkeZ&I esa ,uihih, dks ,slh ubZ vkS”kf/k ds ewY; iwoZ vuqeksnu gsrq vkosnu djuk gksxkA

¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds lwph II ds QkWeZ III dks vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lwpuk ,uihih, dks voxr djk;sxkA blds lEcU/k esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA

¼Tk½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n'kkZ;s vf/kdre ewY; vkSj 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA

dz-la- vuqlwfpr fofufeZfr dk uke [kqjkd :i ,oa izcyrk bdkbZ vf/kdre dher ¼#-½

(1) (2) (3) (4) (5)

1. DyksDlkflfyu dSilwy 250 fexzk- 1 dSilwy 1-02 2. DyksDlkflfyu dSilwy 500 fexzk- 1 dSilwy 1-72

¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 5

¼>½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V ,slh fofufeZfr;ksa ds iSdksa dh vf/kdre dher fu;r gksus ds ifj.kkeLo#i] vf/kdre ;k [kqnjk ewY; fu/kkZfjr vkns'k ;fn dksbZ gks] tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh vf/kØe.k gks tk;saxsA

[dka-la-@180@48@2017@,Q@Qk- la- 8¼48½@2017@Mhih@,uihih,&fMoh-&II]

cythr flag] ] ] ] lgk;d funs'kd

ORDER

New Delhi, the 11th August, 2017

S.O.2602(E).— In exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs

(Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 701(E) dated 10th March,

2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order

of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority)

No. S. O. 2060(E) dated 30th June, 2017 (at Sl. No. 10 & 11) respectively in so far as it relates to formulation packs

mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the

National Pharmaceutical Pricing Authority, hereby fixes the price as specified in column (5) of the table herein below

as ceiling price exclusive of goods and services tax applicable, if any in respect of the Scheduled formulations specified

in the corresponding entry in column (2) of the said Table with the dosage from & strength and unit specified

respectively in the corresponding entries in columns (3) and (4) thereof:

TABLE

Sl. No. Name of the

Scheduled

Formulation

Dosage form &

Strength

Unit Ceiling Price (Rs.)

(1) (2) (3) (4) (5)

1. Cloxacillin Capsule 250mg 1 Capsule 1.02

2. Cloxacillin Capsule 500mg 1 Capsule 1.72

Note:

(a) All manufacturers of scheduled formulations, selling the branded or generic or both the versions of scheduled

formulations at a price higher than the ceiling price (plus goods and services tax as applicable) so fixed and

notified by the Government, shall revise the prices of all such formulations downward not exceeding the

ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any.

(b) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling

price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue

to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.

(c) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the

Government on the ceiling price mentioned in column (5) of the above said table.

(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in

accordance with the ceiling price specified in column (5) of the above table as per provisions contained in

paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V

from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy

to State Drug Controller and dealers.

(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price

list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on

business in a manner so as to be easily accessible to any person wishing to consult the same.

(f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the

above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall

apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the

DPCO, 2013.

(g) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect

of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013

through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation

shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled

formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of

discontinuation.

6 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]

(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to

deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control)

Order, 2013 read with Essential Commodities Act, 1955.

(i) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in

this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of

notification, stand(s) superseded.

[PN/180/48/2017/F/F. No. 8(48)/2017/D.P./NPPA-Div.-II]

BALJIT SINGH, Assistant Director

vkns’kvkns’kvkns’kvkns’k

ubZ fnYyh] 11 vxLr] 2017

dkdkdkdk----vkvkvkvk---- 2603¼v½2603¼v½2603¼v½2603¼v½----&&&&vkS"k/k foHkkx }kjk vkS”k/k ¼ewY; fu;a=.k½] 2013 ds iSjk 31 ds varxZr ikfjr blesa uhps lkj.kh ds LraHk ¼6½ esa fofufnZ”V vkns’kksa ds }kjk tkjh iqufoZyksdu vkns’kksa ds lanHkZ esa fn;s x, funsZ’kksa ds dk;kZUo;u esa vkSj Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 vkSj dk- vk- 701¼v½ rkjh[k 10 ekpZ] 2016 ds lkFk ifBr vkS”k/k ¼dher fu;a=.k½ vkns’k] 2013 ds iSjk 4] 10] 11] 14] 16] 17 vkSj 18 }kjk iznRr ‘kfDr;ksa dk iz;ksx djrs gq, vkSj lkj.kh ds LraHk ¼7½ esa fofufnZ”V Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] ¼jk”Vªh; vkS”k/k ewY; fu/kkZj.k izkf/kdj.k½ ds vkns’kksa ds vf/kdze.k esa] tgk¡ rd mldk lEcU/k uhps dh lkj.kh ds fofufeZfr iSdksa ls gS] mu ckrksa ds flok;] vf/kØkUr djrs gq, ftUgsa ,sls vf/kØe.k ds iwoZ fd;k x;k gS ;k djus dk yksi fd;k x;k gS] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ”V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa Øe’k% rRLFkkuh izfof”V;ksa esa fofufnZ”V [kqjkd :i ,oa izcyrk vkSj bdkbZ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof”V esa fofufnZ”V vuqlwfpr fofufeZfr;ksa esa ls izR;sd ij ykxw oLrq ,oa lsok dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds :i esa fu;r djrh gS%

lkj.khlkj.khlkj.khlkj.kh

dz-la- vuqlwfpr fofufeZfr dk uke

[kqjkd :i ,oa izcyrk

bdkbZ vf/kdre dher ¼#-½

iqufoZyksdu vkns’k la- ,oa rkjh[k

ekStwnk dk- vk- la- ,oa rkjh[k

(1) (2) (3) (4) (5) (6) (7)

1. आईब�ोफन ओरल िल��ड

100 fexzk-@5fefy-

1 िमिल. 0.17935 31015/1/2017-

पीआई.I �दनाक 18.04.2017

2058(अ)

�दनाक

30.6.2017

(�.स..300)

uksV % uksV % uksV % uksV %

¼d½ ljdkj }kjk bl izdkj fu;r dh xbZ vkSj vf/klwfpr dh xbZ vf/kdre dher ¼/ku oLrq ,oa lsok dj] tks ykxw gksa½ ls vf/kd dher ij vuqlwfpr fofufeZfr;ksa ds czkaMsM ;k tsusfjd ;k nksuksa :ikarjksa dks csp jgs vuqlwfpr fofufeZfr;ksa ds lHkh fofuekZrk] mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ¼/ku oLrq ,oa lsok dj] tks ykxw gksa½ ls vf/kd lHkh ,slh fofufeZr;ksa dh dher dk v/kkseq[kh la’kks/ku djsaxsA

¼[k½ mi;qZDr lkj.kh ¼/ku oLrq ,oa lsok dj] tks ykxw gS] ;fn dksbZ gS½ ds LraHk ¼5½ esa fofufnZ”V vf/kdre ewY; dh vis{kk de [kqnjk ewY; okyh Åij of.kZr vuqlwfpr fofufeZfr;ksa ds lHkh ekStwnk fofuekZrk Mhihlhvks] 2013 ds iSjk 13¼2½ ds vuqlkj oLrq ,oa lsok dj ds dk;kZUo;u ij mRikn ‘kqYd vkSj djksa ds varj ds dkj.k vf/kdre [kqnjk ewY; esa gqbZ of) ds vykok ekStwnk vf/kdre [kqnjk ewY; dks fujarj cuk, j[ksaxsA

¼x½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os oLrq ,oa lsok dj dks tksM+ ldrs gSaA

¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr lEcfU/kr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24 ds rgr QkWeZ&V esa vf/klwpuk dh rkjh[k ls vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks ,d ewY; lwph tkjh djsa rFkk mldh dkWih jkT; vkS”kf/k fu;a=dksa vkSj fofuekZrk forjdksa dks tkjh djsaA

¼M+½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds 24 ¼4½ ds mica/kksa ds vuqlkj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i esa ,sls ifjlj] tgka dkjksckj dks bl izdkj fd;k tk jgk gS fd mlls ijke’kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`’; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf’kZr djsxkA

¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 7

¼p½ mi;qZDr lkj.kh esa ;Fkk fofufnZ"V [kqnjk ;k izcyrk ;k nksuksa ds lkFk vuqlwfpr fofufeZfr dk dksbZ ekStwnk fofuekZrk vkS”k/k ewY; fu;a=.k vkns’k] 2013 ds iSjk 2¼;w½ ds vuqlkj dksbZ ubZ vkS”kf/k dks ykap djrk gS rks ,sls ekStwnk fofuekZrk dks vkS”k/k ¼ewY; fu;a=.k½ vkns’k 2013 dh vuqlwph&II ds varxZr ;Fkk fofufnZ”V QkeZ&I esa ,uihih, dks ,slh ubZ vkS”kf/k ds ewY; iwoZ vuqeksnu gsrq vkosnu djuk gksxkA

¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds lwph II ds QkWeZ III dks vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lwpuk ,uihih, dks voxr djk;sxkA blds lEcU/k esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA

¼Tk½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n'kkZ;s vf/kdre ewY; vkSj 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA

¼>½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V ,slh fofufeZfr;ksa ds iSdksa dh vf/kdre dher fu;r gksus ds ifj.kkeLo:i] vf/kdre ;k [kqnjk ewY; fu/kkZfjr vkns'k ;fn dksbZ gks] tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh vf/kØe.k gks tk;saxsA

[dka-la-@180@48@2017@,Q@ Qk- la- 8¼48½@2017@Mhih@,uihih,&fMoh-&II]

cythr flag] ] ] ] lgk;d funs'kd

ORDER

New Delhi, the 11th August, 2017

S.O.2603(E).—In implementation of directions given in line with review orders issued by the Department of

Pharmaceuticals (DOP) vide order(s) specified in column (6) of the table herein below passed by the Department of

Pharmaceuticals under para 31 of Drugs (Prices Control) Order, 2013 and in exercise of the powers conferred by

paragraphs 4, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the

30th May, 2013 and S.O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of

Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India in the Ministry of Chemicals

and Fertilizers (National Pharmaceutical Pricing Authority) specified in the Column (7) of the table regarding

formulation specified in mentioned in the table in so far as it relates to formulation pack mentioned in the table below,

except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing

Authority, hereby fixes/revises the price as specified in column (5) of the table herein below as ceiling price exclusive

of goods and services tax applicable, if any, in respect of the Scheduled formulation(s) specified in the corresponding

entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the

corresponding entries in columns (3) and (4) thereof:

TABLE

Note:

(a) All manufacturers of scheduled formulations, selling the branded or generic or both the versions of scheduled

formulations at a price higher than the ceiling price (plus goods and services tax as applicable) so fixed and

notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling

price specified in column (5) in the above table plus goods and services tax as applicable, if any.

(b) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling

price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to

maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.

(c) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the

Government on the ceiling price mentioned in column (5) of the above said table.

Sl.

No.

Name of the

Scheduled

Formulation

Dosage form &

Strength

Unit Ceiling

Price

(Rs.)

Review Order

number and date

Existing SO number

and date

(1) (2) (3) (4) (5) (6) (7)

1. Ibuprofen Oral Liquid 100mg/5ml 1 ML 0.17935 31015/1/2017-PI.I

dated 18.04.2017

2058(E) dated 30.6.2017

(at Sl. No. 300)

8 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]

(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in

accordance with the ceiling price specified in column (5) of the above table as per provisions contained in

paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from

date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State

Drug Controller and dealers.

(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list,

if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a

manner so as to be easily accessible to any person wishing to consult the same.

(f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above

table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for

prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.

(g) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of

production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through

IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish

information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in

Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.

(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit

the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order,

2013 read with Essential Commodities Act, 1955.

(i) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this

notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of

notification, stand(s) superseded.

[PN/180/48/2017/F/F. No. 8(48)/2017/D.P./NPPA-Div.-II]

BALJIT SINGH, Assistant Director

Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064

and Published by the Controller of Publications, Delhi-110054.